Cancer: A drug-resistant duo

    loading  Checking for direct PDF access through Ovid

Abstract

The efficacy of the anticancer drug vemurafenib, which is used to treat metastatic melanoma, is plagued by acquired resistance. A picture of how such resistance develops is emerging. See Letter p.387

Related Topics

    loading  Loading Related Articles